UMIN ID: UMIN000002020
Registered date:30/05/2009
Specificity of plasma sLOX-1 in emergency patients
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Chest pain (Acute coronary syndrome and others) |
Date of first enrollment | 2009/05/01 |
Target sample size | 100 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | high value of plasma sLOX-1 in patients with STEMI |
---|---|
Secondary Outcome | not high valeu of plasma sLOX-1 in patients without STEMI |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | none |
Related Information
Primary Sponsor | ICU, Chiba Hokusoh Hospital, Nippon Medical School |
---|---|
Secondary Sponsor | Kyoto University |
Source(s) of Monetary Support | Shionogi Pharmetheutics,Shionogi Pharmetheutics |
Secondary ID(s) |
Contact
public contact | |
Name | Noritake Hata |
Address | 1715 Kamagari, Inbamura, Chiba, Japan Japan |
Telephone | 0476-99-1111 |
hata-n@nms.ac.jp | |
Affiliation | Chiba Hokusoh Hospital, Nippon Medical School ICU |
scientific contact | |
Name | Noritake Hata |
Address | 1715 Kamagari, Inbamura, Chiba, Japan Japan |
Telephone | 0476-99-1111 |
Affiliation | Chiba Hokusoh Hospital, Nippon Medical School ICU |